BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38039440)

  • 1. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
    Barkin JA; Harb D; Kort J; Barkin JS
    Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
    Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
    Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
    Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
    Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
    Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
    Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
    Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
    Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis.
    Huang W; de la Iglesia-García D; Baston-Rey I; Calviño-Suarez C; Lariño-Noia J; Iglesias-Garcia J; Shi N; Zhang X; Cai W; Deng L; Moore D; Singh VK; Xia Q; Windsor JA; Domínguez-Muñoz JE; Sutton R
    Dig Dis Sci; 2019 Jul; 64(7):1985-2005. PubMed ID: 31161524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
    Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
    HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
    Dunleavy L; Al-Mukhtar A; Halliday V
    Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider Differences in Monitoring and Management of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis.
    Srivoleti P; Dolan RD; Yang AL; Jin DX; Banks PA; McNabb-Baltar J
    Pancreas; 2022 Jan; 51(1):25-27. PubMed ID: 35195591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
    Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
    Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less common etiologies of exocrine pancreatic insufficiency.
    Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
    World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the diagnosis and management of exocrine pancreatic insufficiency.
    Perbtani Y; Forsmark CE
    F1000Res; 2019; 8():. PubMed ID: 31824646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study].
    Bideeva TV; Maev IV; Kucheryavyy YA; Andreev DN; Shah YS; Lobanova EG; Zaborovskiy AV; Levchenko AI
    Ter Arkh; 2020 Jan; 92(1):30-35. PubMed ID: 32598660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
    Lewis DM; Shahid A
    J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R;
    Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectivity of Pancreatic Enzyme Replacement Therapy in Malnourished Children.
    Güven B; Demir Mis M; Karaman K; Şahin Yaşar A
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):e114-e118. PubMed ID: 32443036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case-control study.
    Alexandre-Heymann L; Yaker F; Lassen PB; Dubois-Laforgue D; Larger E
    Diabetol Metab Syndr; 2024 Feb; 16(1):39. PubMed ID: 38331895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
    Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
    ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.